These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3094267)

  • 1. [Antigenic composition of the gonococcal strains used in preparing a gonorrhea vaccine].
    Andreeva ZM; Shevchenko NM
    Vestn Dermatol Venerol; 1986; (7):33-5. PubMed ID: 3094267
    [No Abstract]   [Full Text] [Related]  

  • 2. [The therapeutic efficacy of a gonococcal vaccine].
    Andreeva ZM; Bednova VN; Shevchenko NM; Malyshev AM; Danilenko TI
    Vestn Dermatol Venerol; 1989; (11):53-5. PubMed ID: 2515676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study of biological properties of lyophilized gonococcal strains for the purpose of their use for vaccine production. 1].
    Korolenko GA; Chaĭko GA; Fedotova IN; Beliaev NV
    Vestn Dermatol Venerol; 1978 Jul; (7):87-9. PubMed ID: 99903
    [No Abstract]   [Full Text] [Related]  

  • 4. Progress Toward a Gonococcal Vaccine: The Way Forward.
    Russell MW; Jerse AE; Gray-Owen SD
    Front Immunol; 2019; 10():2417. PubMed ID: 31681305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neisseria gonorrhoeae vaccine development: hope on the horizon?
    Edwards JL; Jennings MP; Seib KL
    Curr Opin Infect Dis; 2018 Jun; 31(3):246-250. PubMed ID: 29601324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ways and prospects of producing gonococcal vaccine].
    Bednova VN; Dmitriev GA; Pasternak NI
    Vestn Dermatol Venerol; 1987; (11):41-7. PubMed ID: 3125694
    [No Abstract]   [Full Text] [Related]  

  • 7. The primary sequence and antigenic structure of gonococcal pilin: approaches towards a gonococcal vaccine.
    Rothbard JB; Schoolnik GK
    Adv Exp Med Biol; 1985; 185():247-73. PubMed ID: 2416202
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of a gonorrhoea vaccine: prospects, strategies and tactics.
    Gotschlich EC
    Bull World Health Organ; 1984; 62(5):671-80. PubMed ID: 6150769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary studies on the development of a gonococcal vaccine.
    Greenberg I; Diena BB; Kenny CP; Znamirowski R
    Bull World Health Organ; 1971; 45(4):531-5. PubMed ID: 5004708
    [No Abstract]   [Full Text] [Related]  

  • 10. Neisseria gonorrhoeae: stability of typing markers after natural transmission.
    Copley CG; Chiswell CP; Egglestone SI
    Br J Vener Dis; 1983 Aug; 59(4):237-41. PubMed ID: 6409344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a gonococcal cell-wall lectin-adhesin with vaccine potential.
    Perrollet H; Guinet RM
    Ann Sclavo Collana Monogr; 1986; 3(1-2):399-406. PubMed ID: 3122804
    [No Abstract]   [Full Text] [Related]  

  • 12. MetQ of Neisseria gonorrhoeae Is a Surface-Expressed Antigen That Elicits Bactericidal and Functional Blocking Antibodies.
    Semchenko EA; Day CJ; Seib KL
    Infect Immun; 2017 Feb; 85(2):. PubMed ID: 27895130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is gonococcal disease preventable? The importance of understanding immunity and pathogenesis in vaccine development.
    Edwards JL; Jennings MP; Apicella MA; Seib KL
    Crit Rev Microbiol; 2016 Nov; 42(6):928-41. PubMed ID: 26805040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neisseria gonorrhoeae].
    Kuroki T; Yamai S
    Nihon Rinsho; 1999 Nov; 57 Suppl():144-6. PubMed ID: 10635797
    [No Abstract]   [Full Text] [Related]  

  • 15. Detection of Neisseria gonorrhoeae in broth cultures by immunologic methods.
    Lue YA; Ellner PD
    Sex Transm Dis; 1978; 5(1):14-7. PubMed ID: 417408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomics-driven Antigen Discovery for Development of Vaccines Against Gonorrhea.
    Zielke RA; Wierzbicki IH; Baarda BI; Gafken PR; Soge OO; Holmes KK; Jerse AE; Unemo M; Sikora AE
    Mol Cell Proteomics; 2016 Jul; 15(7):2338-55. PubMed ID: 27141096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of gonococcal iron transport systems as potential vaccine antigens.
    Cornelissen CN
    Future Microbiol; 2008 Jun; 3(3):287-98. PubMed ID: 18505395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Protective properties of gonococcal vaccines].
    Ovchinnikov NM; Timchenko GF
    Vestn Dermatol Venerol; 1976 Dec; (12):28-32. PubMed ID: 828819
    [No Abstract]   [Full Text] [Related]  

  • 19. Problems posed by potential gonococcal vaccines viewed from the vantage point of a control agency.
    Robbins JB
    Br J Vener Dis; 1977 Jun; 53(3):170-2. PubMed ID: 406011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine research for gonococcal infections: where are we?
    Jerse AE; Deal CD
    Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv63-8. PubMed ID: 24243883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.